BridgeBio Oncology Therapeutics, Inc(BBOT)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BBOT BridgeBio Oncology Therapeutics, Inc

盘前交易 03-12 05:01:54 EDT

9.99

-0.20

-1.96%

最高10.33	最低9.88	成交量11.45万
今开10.19	昨收10.19	日振幅4.42%
总市值7.99亿	流通市值4.46亿	总股本7,999万
成交额115.13万	换手率0.26%	流通股本4,460万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"BBOT","market":"US","secType":"STK","nameCN":"BridgeBio Oncology Therapeutics, Inc","latestPrice":9.99,"timestamp":1773259200000,"preClose":10.19,"halted":0,"volume":114547,"delay":0,"changeRate":-0.019627085377821325,"floatShares":44603977,"shares":79988687,"eps":-1.676,"marketStatus":"盘前交易","change":-0.2,"latestTime":"03-12 05:01:54 EDT","open":10.19,"high":10.33,"low":9.88,"amount":1151250.385261,"amplitude":0.044161,"askPrice":13,"askSize":65,"bidPrice":4,"bidSize":200,"shortable":3,"etf":0,"ttmEps":-1.676,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1773322200000},"marketStatusCode":1,"adr":0,"listingDate":1707454800000,"exchange":"NASDAQ","adjPreClose":9.99,"postHourTrading":{"tag":"盘后","latestPrice":9.99,"preClose":9.99,"latestTime":"17:48 EDT","volume":830,"amount":8291.7,"timestamp":1773265710507,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.509092315221157},"requestUrl":"/m/hq/s/BBOT/wiki","defaultTab":"wiki","newsList":[{"id":"2612424818","title":"Bridgebio Oncology Therapeutics, Inc.盘中异动 下午盘股价大涨5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2612424818","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2612424818?lang=zh_cn&edition=full","pubTime":"2026-02-19 03:45","pubTimestamp":1771443943,"startTime":"0","endTime":"0","summary":"北京时间2026年02月19日03时45分，Bridgebio Oncology Therapeutics, Inc.股票出现异动，股价大幅拉升5.11%。Bridgebio Oncology Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Bridgebio Oncology Therapeutics, Inc.公司简介：BridgeBio Oncology Therapeutics Inc，前身为BridgeBio Oncology Therapeutics，是一家临床阶段生物技术公司，旨在改变由两种经常发生突变的致癌基因RAS和PI3Ka驱动的癌症的患者生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260219034544a7080f77&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260219034544a7080f77&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","BK4007","BBOT","LENZ"],"gpt_icon":0},{"id":"2603652421","title":"Bridgebio Oncology Therapeutics, Inc.盘中异动 大幅跳水5.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603652421","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603652421?lang=zh_cn&edition=full","pubTime":"2026-01-14 01:36","pubTimestamp":1768325779,"startTime":"0","endTime":"0","summary":"北京时间2026年01月14日01时36分，Bridgebio Oncology Therapeutics, Inc.股票出现异动，股价急速跳水5.76%。Bridgebio Oncology Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.04%。Bridgebio Oncology Therapeutics, Inc.公司简介：BridgeBio Oncology Therapeutics Inc，前身为BridgeBio Oncology Therapeutics，是一家临床阶段生物技术公司，旨在改变由两种经常发生突变的致癌基因RAS和PI3Ka驱动的癌症的患者生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026011401361997a1aabc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026011401361997a1aabc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BBOT","BK4139","LENZ","BK4007"],"gpt_icon":0},{"id":"2602581559","title":"Bridgebio Oncology Therapeutics, Inc.盘中异动 股价大涨5.08%报13.98美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2602581559","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602581559?lang=zh_cn&edition=full","pubTime":"2026-01-09 22:42","pubTimestamp":1767969756,"startTime":"0","endTime":"0","summary":"北京时间2026年01月09日22时42分，Bridgebio Oncology Therapeutics, Inc.股票出现异动，股价快速拉升5.08%。截至发稿，该股报13.98美元/股，成交量3.2084万股，换手率0.04%，振幅3.98%。Bridgebio Oncology Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.00%。Bridgebio Oncology Therapeutics, Inc.公司简介：BridgeBio Oncology Therapeutics Inc，前身为BridgeBio Oncology Therapeutics，是一家临床阶段生物技术公司，旨在改变由两种经常发生突变的致癌基因RAS和PI3Ka驱动的癌症的患者生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260109224236a4b0d664&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260109224236a4b0d664&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BBOT","LENZ","BK4539","BK4007","BK4139"],"gpt_icon":0},{"id":"1177500486","title":"BridgeBio Oncology Therapeutics公布三项创新Ras与Pi3kΑ研发项目临床数据取得新突破","url":"https://stock-news.laohu8.com/highlight/detail?id=1177500486","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1177500486?lang=zh_cn&edition=full","pubTime":"2026-01-07 20:05","pubTimestamp":1767787503,"startTime":"0","endTime":"0","summary":"BridgeBio Oncology Therapeutics公司近日宣布，其三项具备创新性与差异化的Ras及Pi3kΑ管线项目临床研究数据获得显著进展。此次公布的数据进一步验证了公司在肿瘤靶向治疗领域的研发实力，为后续临床试验及潜在疗法开发奠定基础。此次数据更新将推动管线项目向更高阶段的临床研究迈进，为患者提供更具针对性的治疗选择。公司表示将继续与监管机构保持沟通，加速创新疗法的转化进程。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BBOT"],"gpt_icon":0},{"id":"1188895298","title":"Bbot在圣安东尼奥乳腺癌研讨会上发布关于Bbo-10203的最新预临床数据，这是一款首创的Ras:Pi3kΑ抑制剂","url":"https://stock-news.laohu8.com/highlight/detail?id=1188895298","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1188895298?lang=zh_cn&edition=full","pubTime":"2025-12-11 05:06","pubTimestamp":1765400809,"startTime":"0","endTime":"0","summary":"Bbot在圣安东尼奥乳腺癌研讨会上发布关于Bbo-10203的最新预临床数据，这是一款首创的Ras:Pi3kΑ抑制剂。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBOT","BK4139"],"gpt_icon":0},{"id":"1186806847","title":"Leerink Partners首次覆盖BridgeBio Oncology Therapeutics, Inc，给予跑赢大盘评级，目标价25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1186806847","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1186806847?lang=zh_cn&edition=full","pubTime":"2025-09-17 18:21","pubTimestamp":1758104474,"startTime":"0","endTime":"0","summary":"投资银行Leerink Partners近日宣布，开始对BridgeBio Oncology Therapeutics, Inc进行研究覆盖，并给予该股\"跑赢大盘\"评级，目标价格设定为25美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBOT","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.bbotx.com;investors.bbotx.com","stockEarnings":[{"period":"1week","weight":-0.0177},{"period":"1month","weight":-0.0646},{"period":"3month","weight":-0.222},{"period":"6month","weight":-0.0385},{"period":"1year","weight":-0.0664},{"period":"ytd","weight":-0.2021}],"compareEarnings":[{"period":"1week","weight":-0.0128},{"period":"1month","weight":-0.0254},{"period":"3month","weight":-0.0186},{"period":"6month","weight":0.0288},{"period":"1year","weight":0.2166},{"period":"ytd","weight":-0.0082}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"BridgeBio Oncology Therapeutics, Inc.于2021年6月15日作为开曼群岛豁免公司注册成立。自2025年8月12日起，该公司完成了先前宣布的业务合并，合并后的公司注册地位于特拉华州。BBOT是一家临床阶段的生物技术公司，其使命是在RAS和PI3K α这两种最常发生突变的癌基因的驱动下改变癌症患者的生活。","exchange":"NASDAQ","name":"BridgeBio Oncology Therapeutics, Inc","nameEN":"BridgeBio Oncology Therapeutics, Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"BridgeBio Oncology Therapeutics, Inc(BBOT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供BridgeBio Oncology Therapeutics, Inc(BBOT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"BridgeBio Oncology Therapeutics, Inc,BBOT,BridgeBio Oncology Therapeutics, Inc股票,BridgeBio Oncology Therapeutics, Inc股票老虎,BridgeBio Oncology Therapeutics, Inc股票老虎国际,BridgeBio Oncology Therapeutics, Inc行情,BridgeBio Oncology Therapeutics, Inc股票行情,BridgeBio Oncology Therapeutics, Inc股价,BridgeBio Oncology Therapeutics, Inc股市,BridgeBio Oncology Therapeutics, Inc股票价格,BridgeBio Oncology Therapeutics, Inc股票交易,BridgeBio Oncology Therapeutics, Inc股票购买,BridgeBio Oncology Therapeutics, Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"BridgeBio Oncology Therapeutics, Inc(BBOT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供BridgeBio Oncology Therapeutics, Inc(BBOT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}